Based on the data, I would recommend SELL for the stock. Here's my chain of thought:

1. **Valuation**: The trailing PE of 36.48 is relatively high, indicating that the stock is already priced richly. The forward PE of 50.85 is even higher, suggesting that the market expects high growth, but it's uncertain if the company can deliver.
2. **Profitability**: ROE of 15.71% is decent, but not exceptional. Profit Margin of 20.79% is respectable, but not impressive. This suggests that the company's profitability is not exceptionally high.
3. **Growth**: Revenue Growth of 8.1% is moderate, but Earnings Growth of -18.8% is a concern. This indicates that the company's earnings are declining, which is a red flag.
4. **Debt**: Debt/Equity ratio of 3.259 is high, indicating that the company has a significant amount of debt. This increases the risk of investing in the stock.
5. **Industry and Sector**: While Healthcare is a defensive sector, the company's performance is not strong enough to warrant a positive recommendation.

Considering these factors, I believe that the stock is overvalued, and its growth is uncertain. Therefore, I would recommend SELL.